Department of Mathematics, University of Utah, Salt Lake City, UT 84112, USA.
Hepatology. 2012 Aug;56(2):727-34. doi: 10.1002/hep.25656. Epub 2012 Jul 6.
Acetaminophen (APAP) is the leading cause of acute liver injury in the developed world. Timely administration of N-acetylcysteine (N-Ac) prevents the progression of serious liver injury and disease, whereas failure to administer N-Ac within a critical time frame allows disease progression and in the most severe cases may result in liver failure or death. In this situation, liver transplantation may be the only life-saving measure. Thus, the outcome of an APAP overdose depends on the size of the overdose and the time to first administration of N-Ac. We developed a system of differential equations to describe acute liver injury due to APAP overdose. The Model for Acetaminophen-induced Liver Damage (MALD) uses a patient's aspartate aminotransferase (AST), alanine aminotransferase (ALT), and international normalized ratio (INR) measurements on admission to estimate overdose amount, time elapsed since overdose, and outcome. The mathematical model was then tested on 53 patients from the University of Utah. With the addition of serum creatinine, eventual death was predicted with 100% sensitivity, 91% specificity, 67% positive predictive value (PPV), and 100% negative predictive value (NPV) in this retrospective study. Using only initial AST, ALT, and INR measurements, the model accurately predicted subsequent laboratory values for the majority of individual patients. This is the first dynamical rather than statistical approach to determine poor prognosis in patients with life-threatening liver disease due to APAP overdose.
MALD provides a method to estimate overdose amount, time elapsed since overdose, and outcome from patient laboratory values commonly available on admission in cases of acute liver failure due to APAP overdose and should be validated in multicenter prospective evaluation.
在发达世界,对乙酰氨基酚(APAP)是导致急性肝损伤的主要原因。及时给予 N-乙酰半胱氨酸(N-Ac)可防止严重肝损伤和疾病的进展,而在关键时间内未能给予 N-Ac 则允许疾病进展,在最严重的情况下,可能导致肝衰竭或死亡。在这种情况下,肝移植可能是唯一的救命措施。因此,APAP 过量的结果取决于过量的大小和首次给予 N-Ac 的时间。我们开发了一个微分方程系统来描述 APAP 过量引起的急性肝损伤。APAP 诱导的肝损伤模型(MALD)使用患者入院时的天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)和国际标准化比值(INR)测量值来估计过量量、自过量以来的时间流逝和结果。然后在来自犹他大学的 53 名患者中对该数学模型进行了测试。在这项回顾性研究中,通过添加血清肌酐,该模型以 100%的灵敏度、91%的特异性、67%的阳性预测值(PPV)和 100%的阴性预测值(NPV)预测了最终死亡。仅使用初始 AST、ALT 和 INR 测量值,该模型可准确预测大多数个体患者的后续实验室值。这是首次使用动态方法而不是统计方法来确定因 APAP 过量导致危及生命的肝疾病患者的预后不良。
MALD 提供了一种从患者入院时常用的实验室值估算过量量、自过量以来的时间流逝和结果的方法,适用于因 APAP 过量导致的急性肝衰竭,应在多中心前瞻性评估中进行验证。